From my colleague Elaine Chen: Wave Life Sciences said today that interim data show its investigational siRNA therapy cut ...

Although still in Phase I, Wave Life Sciences’ injectable RNA weight loss treatment achieved results that impressed analysts, ...

Could a dusty rock hurtling through space hold the recipe for life? NASA’s latest analysis of asteroid Bennu’s pristine ...

REVEAL GENOMICS, S.L., a Barcelona-based biotechnology company focused on advancing precision oncology through biomarker ...

Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to ...

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

An announcement from Sarepta Therapeutics ( ($SRPT) ) is now available. On December 7, 2025, Sarepta Therapeutics‘ Board of Directors granted ...

Replicate Bioscience & Instituto Butantan ink collaboration to develop and commercialize Replicate’s srRNA rabies vaccine in Latin America: San Diego, California Monday, Decembe ...

Presented new data in non-human primates (NHP) for sickle cell disease (SCD), where RNA Gene Writer achieved approximately 40% and 60% of long-term hematopoietic stem cells (LT-HSCs) with at least one ...

An end-of-the-year slowdown has not been witnessed by the biopharma industry yet, and certainly not in the biotech deals ...

In the latest research, led by experts at UT Southwestern, biologist Jun Wu identified a mouse cell protein named MAVS, which ...

Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA ...